Global Asthma Network Logo Global Asthma Network Global Asthma Network Logo
  • The Global Asthma Network strives for a world where no-one suffers from asthma

  • The Global Asthma Network is the asthma surveillance hub for the world

  • The Global Asthma Network researches ways of reducing the burden of asthma

  • The Global Asthma Network promotes access to appropriate asthma management

  • The Global Asthma Network stimulates and encourages capacity building in LMICs

  • The Global Asthma Network strives to ensure access to quality-assured essential asthma medications

  • The Global Asthma Network raises the profile of asthma as a major NCD

Respiratory and Allergy Organisations

ISAAC

The International Study of Asthma and Allergies in Childhood (ISAAC) is the largest collaborative epidemiological study of children in the world. ISAAC has measured the symptom prevalence of asthma, rhinitis and eczema in almost 2 million children in 105 countries. The ISAAC findings have demonstrated that asthma and allergies are a global health problem and environmental factors are key. The ISAAC methodology and surveillance tools have been adopted by the epidemiological community and are widely used in studies of asthma, rhinitis and eczema throughout the world.

Website

The ISAAC Story

A complete history of ISAAC, The International Study of Asthma and Allergies in Childhood, including its tools and methodologies. This unique worldwide epidemiological research programme established in 1991 to investigate asthma, rhinitis and eczema in children became the largest worldwide collaborative research project ever undertaken, involving more than 100 countries and nearly 2 million children. ISAAC findings are cited by any organization involved in monitoring and preventing chronic respiratory diseases and are used to inform global health initiatives which include WHO, and its NGO the Global Alliance against Chronic Respiratory Diseases (GARD).

ISAAC Symposium 2011

Presentations from The ISAAC 20 year Anniversary Symposium held in Auckland, New Zealand in January 2011, on recent research and findings in the fields of asthma, eczema, and rhinitis, available to download.